• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The International journal of pharmacy practice >Reclassif ication of omeprazole: a survey of community pharmacists' early experiences and views
【24h】

Reclassif ication of omeprazole: a survey of community pharmacists' early experiences and views

机译：奥美拉唑的重新分类：一项社区药师的早期经验和观点调查

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective To describe community pharmacists' views and early experiences of over-the-counter (OTC) omeprazole.Method A cross-sectional pre-piloted postal questionnaire was sent to 2000 randomly selected community pharmacy premises in Great Britain (approximately 15%). The questionnaire comprised items on: attitudes to OTC omeprazole; continuing education; sales; and general views and experiences. Two reminders were sent. Data were analysed using descriptive statistics.Results Questionnaires were returned by 1156 community pharmacists (57.8%). Sixty-eight per cent of respondents had not sold any omeprazole in the previous 14 days and a further 12% had sold only a single pack in this period. In total 920/1147 pharmacists (80.2%) had participated in continuing education on omeprazole, 73.4% agreed or strongly agreed that they were entirely confident in selling it, and 78.0% viewed omeprazole as a welcome addition to OTC medicines. Some 17.6% of respondents had recommended purchase of omeprazole in the last 14 days and the vast majority of these recommendations (92.8%) were accepted by the customer. Forty-one pharmacists (3.5%) had refused sales on the basis that it was inappropriate for the presenting condition, or due to a potential drug interaction.Conclusion Many responding community pharmacists welcome omeprazole availability OTC and are willing and able to supply it.
机译：目的描述社区药剂师对非处方奥美拉唑（OTC）的看法和早期经验。方法将横截面预试邮寄问卷发送到英国2000个随机选择的社区药房（约15％）。该问卷包括以下项目：对OTC奥美拉唑的态度;继续教育;销售;以及一般观点和经验。发送了两个提醒。使用描述性统计数据对数据进行分析。结果调查问卷由1156位社区药师（57.8％）返回。 68％的受访者在过去14天内未售出任何奥美拉唑，另有12％的受访者在此期间仅售出了一包。共有920/1147名药剂师（80.2％）参加了奥美拉唑的继续教育，73.4％同意或强烈同意他们完全有信心出售奥美拉唑，而78.0％的药剂师认为奥美拉唑是OTC药物中受欢迎的补充。约有17.6％的受访者在过去14天内建议购买奥美拉唑，而这些建议中的绝大多数（92.8％）被客户接受。有41位药剂师（3.5％）拒绝了该药物的销售，原因是该药物不适合当前情况或潜在的药物相互作用。结论许多对此作出回应的社区药剂师欢迎奥美拉唑的OTC可用性，并愿意并能够提供。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号